Home / Conditions / Type 2 Diabetes (page 48)

Type 2 Diabetes

Type 2 Diabetes Research and News: Type 2 diabetes is a metabolic disorder. Though most commonly diagnosed in the elderly, younger adults and even children are increasingly subject to the disease. 9.4% of the US population has Type 2 diabetes or about 30 million Americans. Approximately 95% of all adults diagnosed with diabetes have Type 2. New tools, techniques and treatments can help you improve outcomes for your Type 2 diabetes patients.

Personalized Medicine in Type 2 Diabetes

Precision medicine is the revolutionary new way of treating type 2 diabetes, a chronic health condition that affects millions of individuals across the world. This innovative approach to personalized healthcare has been made possible by recent advances in genetics, technology and data analytics. Through precision medicine, doctors can develop tailored …

Read More »

Type 2 Diabetes: Recent Guidelines for Cardiovascular Risk Reduction

Recent Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes have been established to help control the risks associated with this chronic condition. These guidelines are focused on reducing the risk of heart attack, stroke, and other cardiovascular diseases (CVDs) through lifestyle changes and medications. The American Diabetes …

Read More »

Improving Insulin Sensitivity

Insulin sensitivity is an important factor in the management of diabetes, as it affects how well your body can use insulin to make glucose available to cells for energy. Improving insulin sensitivity is an important goal for people with diabetes, and researchers are continually looking for new ways to do …

Read More »

Tirzepatide: A Dual GLP-1/GIP Receptor Agonist for the Treatment of T2D

Authors: Ashley Wagnild, PharmD Candidate 2024, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 54-year-old man was referred to the pharmacotherapy clinic by his primary care provider (PCP) for a therapy consult. The patient had a past medical …

Read More »

Bromocriptine-QR Therapy and its Impact on the Pro-inflammatory State of Type 2 Diabetes Subjects in Relation to CVD

Sponsored Content  Bromocriptine-QR (Cycloset) “is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mechanisms.” This study investigated the impact of Cycloset on the pro-inflammatory state …

Read More »

Could Dapagliflozin Be Beneficial in The Treatment of Patients with Type 2 Diabetes and Multiple Risk Factors

What are the effects of prescribing sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and multiple risk factors? Type 2 diabetes (T2D) usually occurs with multiple risk factors and complications. When treating patients with T2D targeting several risk factors, especially in the early stages of the disease state, …

Read More »